NCT05552209

Brief Summary

Decathlon has developed elbowMID500 and elbowSTRAP products which are medical devices that must be positioned around the elbow during sport practice, in order to limit symptoms related to epicondylitis or previous sprains (elbowMID500 only). The objective of this multicentre study is to collect data on the related clinical complications and clinical outcomes of market-approved Decathlon elbowMID500 and elbowSTRAP products to demonstrate safety and performance of these devices in a real-world setting. Outcome data collected from this study will provide the basis for Post-Market Surveillance (PMS) reporting, Clinical Study Report (CSR), Clinical Evaluation Report (CER) on Decathlon elbowMID500 and elbowSTRAP devices and support peer-reviewed publications on products performance and safety.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 13, 2022

Completed
8 days until next milestone

Study Start

First participant enrolled

September 21, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 23, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2023

Completed
Last Updated

January 17, 2023

Status Verified

January 1, 2023

Enrollment Period

1 year

First QC Date

September 13, 2022

Last Update Submit

January 13, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Functional score

    Comparison of the Japanese Elbow Assessment Score System (JOA elbow scale from 0=worst ouctome to 100=best outcome) between the baseline and last follow-up visit in each group (orthosis vs control), for each device model.

    Change from Baseline functionnal score at 6 weeks

Secondary Outcomes (3)

  • Confidence level (confidence questionnaire related to physical activity)

    Change from Baseline confidence level at 6 weeks

  • Elbow pain

    Change from Baseline elbow pain at 6 weeks

  • Safety (adverse events)

    6 weeks of follow-up

Study Arms (4)

Orthosis group 1

Use of Elbow Mid 500 device during sport practice

Device: Elbow MID 500

Control group 1

Control group of the Elbow Mid 500 group - no medical device used during sport practice

Other: Control group Elbow MID 500

Orthosis group 2

Use of Elbow Strap device during sport practice

Device: Elbow STRAP

Control group 2

Control group of the Elbow Strap group - no medical device used during sport practice

Other: Control group Elbow STRAP

Interventions

15 patients will be included in this group and will used the medical device Elbow MID 500 during sport practice (at least 2 sport sessions per week), for 6 weeks.

Orthosis group 1

15 patients will be included in this control group and will performed their sport sessions as usual (without the medical device Elbow MID 500), for at least 2 sport sessions per week during 6 weeks.

Control group 1

15 patients will be included in this group and will used the medical device Elbow STRAP during sport practice (at least 2 sport sessions per week), for 6 weeks.

Orthosis group 2

15 patients will be included in this control group and will performed their sport sessions as usual (without the medical device Elbow STRAP), for at least 2 sport sessions per week during 6 weeks.

Control group 2

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects with acute epicondylitis (stage 1 or 2) or a recent mild elbow sprain whose current condition of their elbow allows them to pursue a usual physical activity.

You may qualify if:

  • Subject is aged ≥ 18 years old
  • Subject has an acute epicondylitis (stage 1 or 2) OR a recent mild elbow sprain
  • Subject performs regular physical activity (minimum of 2 sessions of 10 minutes per week)
  • The current condition of his/her elbow allows the subject to resume usual physical activity
  • Subject has been informed and is willing to sign an informed consent form
  • Subject is willing to comply with protocol requirements and return to the study center for all clinical evaluations and required follow-up (6 weeks)
  • Subject is affiliated to the French social security regime

You may not qualify if:

  • Subject has conditions that may interfere with his/her ability to understand protocol requirements, participate in scheduled visits, or provide his/her informed consent
  • Subject has worn a support (elbow brace or articulated orthosis) in the last month during his/her sport practice
  • Subject has resumed regular physical activity since his/her recent injury
  • Subject has any medical condition that could impact the study at investigator's discretion
  • Subject has a known hypersensitivity or allergy to the components of the device (polyamide, elastane, polyester, elastodiene) • Adult subject to legal protection measure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Centre Hospitalier de Boulogne sur Mer

Boulogne-sur-Mer, 62200, France

RECRUITING

Centre de rééducation et de balnéothérapie Kinés Faches

Faches-Thumesnil, 59155, France

RECRUITING

Centre Hospitalier Universitaire de Lille

Lille, 59000, France

NOT YET RECRUITING

Cabinet de kinésithérapie du Belvédère

Paris, 75019, France

NOT YET RECRUITING

Study Officials

  • Valérie WIECZOREK

    Centre Hospitalier Universitaire de Lille

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sophie TALLON

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2022

First Posted

September 23, 2022

Study Start

September 21, 2022

Primary Completion

October 1, 2023

Study Completion

October 1, 2023

Last Updated

January 17, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations